Page last updated: 2024-08-24

2-methoxyestradiol and Acute Lymphoid Leukemia

2-methoxyestradiol has been researched along with Acute Lymphoid Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chagraoui, J; Fares, I; Geoffrion, D; Gerby, B; Haman, A; Hébert, J; Hoang, T; Kosic, M; Krosl, J; Kwok, BH; Lavoie, G; Litalien, V; Maddox, PS; Marinier, A; Nourreddine, S; Ottoni, E; Ouellette, J; Roux, PP; Ryan, J; Sauvageau, G; Tremblay, M; Veiga, DF1
Cunningham, AM; Hibbs, DE; Kavallaris, M; Liaw, TY; McKay, MJ; Salam, NK1

Other Studies

2 other study(ies) available for 2-methoxyestradiol and Acute Lymphoid Leukemia

ArticleYear
High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.
    The Journal of clinical investigation, 2016, 12-01, Volume: 126, Issue:12

    Topics: 2-Methoxyestradiol; Animals; Basic Helix-Loop-Helix Transcription Factors; DNA-Binding Proteins; Estradiol; Humans; Jurkat Cells; LIM Domain Proteins; Mice; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins; Receptor, Notch1; T-Cell Acute Lymphocytic Leukemia Protein 1; Transcription Factors; Tumor Microenvironment; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays

2016
Class I beta-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions.
    Molecular cancer therapeutics, 2008, Volume: 7, Issue:10

    Topics: 2-Methoxyestradiol; Acetylation; Amino Acid Sequence; Cell Line, Tumor; Drug Resistance, Neoplasm; Estradiol; G2 Phase; Humans; Immunohistochemistry; Microscopy, Confocal; Mitosis; Models, Molecular; Molecular Sequence Data; Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Structural Homology, Protein; Tubulin

2008